Featured Research

from universities, journals, and other organizations

'Bionic Eye' May Help Blind See: Retinal Prosthesis Shown To Restore Partial Vision

Date:
October 21, 2009
Source:
Society for Neuroscience
Summary:
A new artificial retina, an array of electrodes implanted on the back of the eye, has been found to restore partial vision to totally blind people. In a study focused on 15 blind participants who had the implant for at least three months, 10 of the patients subsequently tested were able to identify the direction of moving objects.

Researchers have found that an array of electrodes implanted on the back of the eye can restore partial vision to totally blind people.
Credit: Jessy Dorn / Second Sight Medical Products, Inc.

A new artificial retina, an array of electrodes implanted on the back of the eye, has been found to restore partial vision to totally blind people. In a study focused on 15 blind participants who had the implant for at least three months, 10 of the patients subsequently tested were able to identify the direction of moving objects.

The research was presented at Neuroscience 2009, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news about brain science and health.

"These results give new hope to the many people with degenerative retinal diseases," said Jessy Dorn, PhD, of Second Sight Medical Products, Inc., lead author of the study. More than two million Americans suffer from eye diseases such as retinitis pigmentosa and age-related macular degeneration, slowly losing their vision as the nerve cells that detect light are destroyed, due to either age or illness. There is no known cure.

In this case, the researchers worked around the destroyed cells. Each participant was given a pair of glasses with a small video camera mounted on it, and a belt with a tiny computer attached. The computer processed video images from the camera and transmitted the data to the implanted electrodes on the retina. When the users "looked" at a monitor with a white bar sweeping across a black screen, the electrodes that corresponded with the moving bar stimulated cells in the eye, creating spots of light in their fields of vision.

"We found that most of the study participants were better able to determine the direction of the bar when using the prosthesis system than without it, or with a scrambled video input," Dorn said. "In other words, this new system gave most blind people the ability to identify an object's direction of motion -- something they could not do without it." An international clinical trial is now testing the prosthesis system. To date, 32 blind people have received the implant.

Research was supported by the National Eye Institute.


Story Source:

The above story is based on materials provided by Society for Neuroscience. Note: Materials may be edited for content and length.


Cite This Page:

Society for Neuroscience. "'Bionic Eye' May Help Blind See: Retinal Prosthesis Shown To Restore Partial Vision." ScienceDaily. ScienceDaily, 21 October 2009. <www.sciencedaily.com/releases/2009/10/091021012847.htm>.
Society for Neuroscience. (2009, October 21). 'Bionic Eye' May Help Blind See: Retinal Prosthesis Shown To Restore Partial Vision. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2009/10/091021012847.htm
Society for Neuroscience. "'Bionic Eye' May Help Blind See: Retinal Prosthesis Shown To Restore Partial Vision." ScienceDaily. www.sciencedaily.com/releases/2009/10/091021012847.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins